127 related articles for article (PubMed ID: 10743954)
1. Rational design, synthesis and structure-activity relationships of antitumor (E)-2-benzylidene-1-tetralones and (E)-2-benzylidene-1-indanones.
Shih H; Deng L; Carrera CJ; Adachi S; Cottam HB; Carson DA
Bioorg Med Chem Lett; 2000 Mar; 10(5):487-90. PubMed ID: 10743954
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antineoplastic evaluation of certain 16-(4-substituted benzylidene) derivatives of androst-5-ene.
Dubey S; Piplani P; Jindal DP
Chem Biodivers; 2004 Oct; 1(10):1529-36. PubMed ID: 17191796
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, evaluation and QSAR studies of 16-(4 & 3,4-substituted) benzylidene androstene derivatives as anticancer agents.
Dubey S; Kaur P; Jindal DP; Satyanarayan YD; Piplani P
Med Chem; 2008 May; 4(3):229-36. PubMed ID: 18473915
[TBL] [Abstract][Full Text] [Related]
4. Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study.
Nakhjiri M; Safavi M; Alipour E; Emami S; Atash AF; Jafari-Zavareh M; Ardestani SK; Khoshneviszadeh M; Foroumadi A; Shafiee A
Eur J Med Chem; 2012 Apr; 50():113-23. PubMed ID: 22341788
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
Alam MS; Lee DU
Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activities of substituted 3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones and studies on their mechanisms of action.
Andreani A; Granaiola M; Locatelli A; Morigi R; Rambaldi M; Varoli L; Vieceli Dalla Sega F; Prata C; Nguyen TL; Bai R; Hamel E
Eur J Med Chem; 2013 Jun; 64():603-12. PubMed ID: 23685944
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of 10-substituted benzylidene anthrone.
Hu W; Zhou W
Bioorg Med Chem Lett; 2004 Feb; 14(3):621-2. PubMed ID: 14741255
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel benzylidene analogues of betulinic acid as potent cytotoxic agents.
Gupta N; Rath SK; Singh J; Qayum A; Singh S; Sangwan PL
Eur J Med Chem; 2017 Jul; 135():517-530. PubMed ID: 28500966
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
[TBL] [Abstract][Full Text] [Related]
10. 6-Benzylidene-2-[4-(pyridin-3-ylcarboxy)benzylidene]cyclohexanones: A novel cluster of tumour-selective cytotoxins.
Panda AK; Das U; Umemura N; Sakagami H; Kawase M; Balzarini J; De Clercq E; Dimmock SG; Roayapalley PK; Dimmock JR
Bioorg Med Chem Lett; 2017 Apr; 27(7):1611-1615. PubMed ID: 28238612
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic evaluation of usnic acid benzylidene derivatives as potential anticancer agents.
Nguyen VK; Sichaem J; Nguyen HH; Nguyen XH; Huynh TT; Nguyen TP; Niamnont N; Mac DH; Pham DD; Chavasiri W; Nguyen KP; Duong TH
Nat Prod Res; 2021 Apr; 35(7):1097-1106. PubMed ID: 31303058
[TBL] [Abstract][Full Text] [Related]
12. 5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line.
Zuliani V; Carmi C; Rivara M; Fantini M; Lodola A; Vacondio F; Bordi F; Plazzi PV; Cavazzoni A; Galetti M; Alfieri RR; Petronini PG; Mor M
Eur J Med Chem; 2009 Sep; 44(9):3471-9. PubMed ID: 19268405
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and CYP24A1 inhibitory activity of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones.
Aboraia AS; Makowski B; Bahja A; Prosser D; Brancale A; Jones G; Simons C
Eur J Med Chem; 2010 Oct; 45(10):4427-34. PubMed ID: 20655626
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization.
Prakasham AP; Saxena AK; Luqman S; Chanda D; Kaur T; Gupta A; Yadav DK; Chanotiya CS; Shanker K; Khan F; Negi AS
Bioorg Med Chem; 2012 May; 20(9):3049-57. PubMed ID: 22472045
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives.
Patil V; Tilekar K; Mehendale-Munj S; Mohan R; Ramaa CS
Eur J Med Chem; 2010 Oct; 45(10):4539-44. PubMed ID: 20667627
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antileukemic activity of 16E-[4-(2-carboxy)ethoxybenzylidene]-androstene amides.
Bansal R; Acharya PC
Steroids; 2012 Apr; 77(5):552-7. PubMed ID: 22326415
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines.
Cheng H; Zhang L; Liu Y; Chen S; Cheng H; Lu X; Zheng Z; Zhou GC
Eur J Med Chem; 2010 Dec; 45(12):5950-7. PubMed ID: 20974505
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antimicrobial and anticancer evaluation of N'-(substituted benzylidene)-2-(benzo[d]oxazol-3(2H)-yl)acetohydrazide derivatives.
Rohilla P; Deep A; Kamra M; Narasimhan B; Ramasamy K; Mani V; Mishra RK; Lim SM
Drug Res (Stuttg); 2014 Oct; 64(10):505-9. PubMed ID: 24992500
[TBL] [Abstract][Full Text] [Related]
19. 3,5-Bis-benzylidene-4-piperidones and related compounds with high activity towards P388 leukemia cells.
Dimmock JR; Arora VK; Wonko SL; Hamon NW; Quail JW; Jia Z; Warrington RC; Fang WD; Lee JS
Drug Des Deliv; 1990 Sep; 6(3):183-94. PubMed ID: 2076179
[TBL] [Abstract][Full Text] [Related]
20. Discovery and structure-activity relationships of (2-(arylthio)benzylideneamino)guanidines as a novel series of potent apoptosis inducers.
Zhang HZ; Crogan-Grundy C; May C; Drewe J; Tseng B; Cai SX
Bioorg Med Chem; 2009 Apr; 17(7):2852-8. PubMed ID: 19282188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
